Stocks and Investing Stocks and Investing
Tue, November 23, 2021

Justin Smith Upgraded (ABBV) to Strong Buy and Held Target at $172 on, Nov 23rd, 2021


Published on 2024-10-27 18:45:30 - WOPRAI, Justin Smith
  Print publication without navigation


Justin Smith of Societe Generale, Upgraded "AbbVie Inc." (ABBV) to Strong Buy and Held Target at $172 on, Nov 23rd, 2021.

Justin has made no other calls on ABBV in the last 4 months.



There are 8 other peers that have a rating on ABBV. Out of the 8 peers that are also analyzing ABBV, 2 agree with Justin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $118 on, Monday, November 1st, 2021
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $119 on, Monday, August 2nd, 2021


These are the ratings of the 6 analyists that currently disagree with Justin


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $129 on, Monday, November 1st, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $135 on, Monday, November 1st, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $124 on, Monday, November 1st, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $132 on, Monday, November 1st, 2021
  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $130 on, Monday, August 23rd, 2021
  • Robyn Karnauskas of "Truist Securities" Initiated at Strong Buy and Held Target at $118 on, Monday, July 26th, 2021
Contributing Sources